Loading...
RYI is not a good buy right now. The chart setup is weakening (bearish MACD), insiders are selling aggressively, and the next major catalyst is an earnings release (Feb 19) that could easily move the stock against you. With no proprietary buy signals today and limited supportive options volume, the risk/reward does not favor an impatient “buy now” entry.
Price/Trend: RYI is trading at 28.07 (-0.50%), slightly below the pivot (28.758) and sitting between support S1 (27.612) and resistance R1 (29.904). Momentum: MACD histogram is -0.256 and negatively expanding, which points to increasing downside momentum. RSI(6) is 47.96 (neutral), so there’s no oversold bounce signal to lean on. Moving averages are converging, suggesting consolidation, but the bearish MACD tilt implies the consolidation is vulnerable to a breakdown toward 27.61 and potentially 26.90 (S2) if selling pressure increases. Near-term probabilities (pattern-based): modest upside odds over 1 day/week, but a negative bias over the next month (-3.22%), which aligns with the bearish momentum reading.

Any surprise improvement in profitability/margins or a constructive 2026 outlook could re-rate the stock short-term. Short-term technical setup: price is close to S1 (27.612); if it holds and reclaims the pivot (28.758), a move toward ~29.90 (R
is plausible.
Technical momentum: bearish, expanding negative MACD suggests downside momentum is building rather than stabilizing. Options confirmation is weak: despite call-heavy open interest, near-zero volume reduces confidence in that bullish read.
Latest quarter (2025/Q3): Revenue rose to $1.1615B (+3.10% YoY), showing modest top-line growth. Losses narrowed: Net income improved to -$14.8M (up 124.24% YoY) and EPS improved to -0.46 (up 130.00% YoY), indicating progress toward better profitability versus the prior year period. However, gross margin fell to 17.18% (-4.18% YoY), which is a key concern—margin compression can offset revenue gains and is especially important for cyclical metals/service-center businesses.
No analyst rating trend or price target change data was provided, so a verified summary of recent upgrades/downgrades and target revisions cannot be made from the dataset. Wall Street-style pros view (based on available fundamentals): improving YoY earnings/loss trajectory and modest revenue growth. Cons view: declining gross margin, cyclical sensitivity, and the strong recent insider selling signal.